Bioequivalence study of lamotrigine tablets in healthy male human volunteers

Indian Drugs

Volumn 35, Issue 9, 1998, Pages 570-573

  Sane, R T ^a   Francis, Mary ^b   Deo, Adwait ^b  

^a SP Mandali's Therapeut Drug M   (India)

^b NONE

Author keywords

Bioequivalence; Lamotrigine Pharmacokinetic; Reverse Phase HPLC

Indexed keywords

LAMOTRIGINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MONITORING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031666738     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. The Merck Index - 12th editions. Published by Merck & Co., Inc. USA. 1996.
2. Therapeutic Drugs - Supplement 2, Edited by Sir Collin Dollery, Published by Churchill Livingstone London, 1991.
3. Fraser A.D., Macneil W., Isner A.F., Camfield P.R. Therapeutic. Drug. Monitoring, 1995, (17) (2). 174-178.
4. Meyler, M., Kelly M. T., Smyth M.R. Chomatographia, 1993, 36, 27-32.
5. Ramachandran S., Underhill S., Jones S. R. Therapeutic Drug Monitoring 1992, 14(6), 509-512.
6. Fazio A., Artesi C., Russo M., Trio Oteri G., Pisani F. Therapeutic Drug Monitoring, 1992, 14(6), 509-512.